Pharmaceuticals, Biotechnology and Life Sciences
AUSTIN, Texas–(BUSINESS WIRE)–TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based…
Continued clinical progress with lead compound Voriconazole Inhalation Powder, to treat invasive pulmonary aspergillosis (IPA) Tacrolimus Inhalation Powder for immunosuppression…
Continued clinical progress with lead compound Voriconazole Inhalation Powder, to treat invasive pulmonary aspergillosis (IPA) Tacrolimus Inhalation Powder for immunosuppression…
Nationally Recognized Expert in Dry Eye Disease, Allergic Conjunctivitis, and Other Ocular Surface Diseases LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq:…
Nationally Recognized Expert in Dry Eye Disease, Allergic Conjunctivitis, and Other Ocular Surface Diseases LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq:…
WOBURN, Mass.–(BUSINESS WIRE)–#AIDS–Aphios Corporation today announced that it was issued US Patent No. 10,493,030 for the treatment of HIV latency…
CHENGDU, China–(BUSINESS WIRE)–Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced that…
DUBLIN–(BUSINESS WIRE)–The “Cough Hypersensitivity Syndrome Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027”…
DUBLIN–(BUSINESS WIRE)–The “Cough Hypersensitivity Syndrome Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027”…
WILMINGTON, Del.–(BUSINESS WIRE)–$INCY–Incyte (Nasdaq:INCY) today announced positive topline results from its randomized, vehicle-controlled, pivotal Phase 3 TRuE-AD2 study evaluating the…